Atlas Trials

Amylyx Pharmaceuticals Inc.

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Amylyx Pharmaceuticals Inc.

RecordFirmDate
Avexitide for Treatment of Post-Bariatric Hypoglycemia (NCT06747468)Amylyx Pharmaceuticals Inc.2025-04-29
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis (NCT06665165)Amylyx Pharmaceuticals Inc.2025-04-07
AMX0035 and Progressive Supranuclear Palsy (NCT06122662)Amylyx Pharmaceuticals Inc.2023-12-21
AMX0035 in Adult Patients With Wolfram Syndrome (NCT05676034)Amylyx Pharmaceuticals Inc.2023-03-03
Extension Study Evaluating The Safety And Tolerability of AMX0035 (NCT05619783)Amylyx Pharmaceuticals Inc.2022-12-29
Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment (NCT05021536)Amylyx Pharmaceuticals Inc.2021-10-28
Pharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALS (NCT04987671)Amylyx Pharmaceuticals Inc.2021-08-05
A Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT04516096)Amylyx Pharmaceuticals Inc.2020-11-22
Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease (NCT03533257)Amylyx Pharmaceuticals Inc.2018-09-14
Open Label Extension Study of AMX0035 in Patients With ALS (NCT03488524)Amylyx Pharmaceuticals Inc.2018-03-29

Track Amylyx Pharmaceuticals Inc. automatically

Every clearance here is in the API, with alerts when new ones post.